Pigment epithelium-derived factor (PEDF) blocks high glucose-induced inflammatory reactions in endothelial cells through its anti-oxidative properties

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 3004-3006

  Nakashima, Sae ^a   Matsui, Takanori ^a   Yamagishi, Sho Ichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endothelial cells; High glucose; Inflammation; PEDF

Indexed keywords

EYE PROTEIN; GLUCOSE; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; REACTIVE OXYGEN METABOLITE; SERINE PROTEINASE INHIBITOR;

CELL CULTURE; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

CELLS, CULTURED; ENDOTHELIAL CELLS; EYE PROTEINS; GLUCOSE; HUMANS; INFLAMMATION; NERVE GROWTH FACTORS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SERPINS;

EID: 84885655050     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.04.003     Document Type: Article

References (20)

1. S. Yamagishi, and T. Imaizumi Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy Curr Pharm Des 11 2005 2279 2299
2. M. Laakso Hyperglycemia and cardiovascular disease in type 2 diabetes Diabetes 48 1999 937 942
3. S. Yamagishi, T. Matsui, and K. Nakamura Blockade of the advanced glycation end products (AGEs) and their receptor (RAGE) system is a possible mechanism for sustained beneficial effects of multifactorial intervention on mortality in type 2 diabetes Med Hypotheses 71 2008 749 751
4. J. Tombran-Tink, C.G. Chader, and L.V. Johnson PEDF: pigment epithelium-derived factor with potent neuronal differentiative activity Exp Eye Res 53 1991 411 414
5. S. Yamagishi, and T. Matsui Anti-atherothrombogenic properties of PEDF Curr Mol Med 10 2010 284 291
6. S. Maeda, T. Matsui, and M. Takeuchi Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis Pharmacol Res 63 2011 241 248
7. Y. Yoshida, S. Yamagishi, and T. Matsui Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy Diabetes Metab Res Rev 25 2009 678 686
8. S. Yamagishi, Y. Inagaki, S. Amano, T. Okamoto, M. Takeuchi, and Z. Makita Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties Biochem Biophys Res Commun 296 2002 877 882
9. S. Yamagishi, D. Edelstein, X.L. Du, Y. Kaneda, M. Guzmán, and M. Brownlee Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A J Biol Chem 276 2001 25096 25100
10. Y. Ide, T. Matsui, Y. Ishibashi, M. Takeuchi, and S. Yamagishi Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation Microvasc Res 80 2010 227 232
11. S. Maeda, T. Matsui, M. Takeuchi, and S. Yamagishi Co-treatment with azelinidipine and olmesartan inhibits advanced glycation end products (AGEs) elicited down-regulation of adiponectin mRNA levels in cultured adipocytes partly via its anti-oxidative property Int J Cardiol 146 2011 264 266
12. T. Nishikawa, D. Edelstein, and X.L. Du Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 2000 787 790
13. Z. Zheng, H. Chen, and H. Zhao Inhibition of JAK2/STAT3-mediated VEGF upregulation under high glucose conditions by PEDF through a mitochondrial ROS pathway in vitro Invest Ophthalmol Vis Sci 51 2010 64 71
14. S. Amano, S. Yamagishi, and Y. Inagaki Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes Microvasc Res 69 2005 45 55
15. S. Yamagishi, T. Matsui, and K. Nakamura Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species Ophthalmic Res 40 2008 10 15
16. S. Yamagishi, K. Nakamura, S. Ueda, S. Kato, and T. Imaizumi Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF Cell Tissue Res 320 2005 437 445
17. Z. Tumur, H. Shimizu, A. Enomoto, H. Miyazaki, and T. Niwa Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation Am J Nephrol 31 2010 435 441
18. B. Coll, C. Alonso-Villaverde, and J. Joven Monocyte chemoattractant protein-1 and atherosclerosis: is there room for an additional biomarker? Clin Chim Acta 383 2007 21 29
19. E. Galkina, and K. Ley Vascular adhesion molecules in atherosclerosis Arterioscler Thromb Vasc Biol 27 2007 2292 2301
20. S. Yamagishi, K. Nakamura, and T. Matsui Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression J Biol Chem 281 2006 20213 20220